参考文献/References:
[1] Vandijk EJ,Prins ND,Vrooman HA,et al.Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences-rotterdam scan study[J].Stroke,2008,39(10):2712-2719.
[2] Moran C,Phan TG,Srikanth VK.Cerebral small vessel disease:A review of clinical,radiological,and histopathological phenotypes[J].International Journal of Stroke,2012,7(1):36-46.
[3] Bernbaum M,Menon BK,Fick G,et al.Reduced blood flow in normal white matter predicts development of leukoaraiosis[J].Journal of Cerebral Blood Flow and Metabolism,2015,35(10):1610-1615.
[4] Shi YL,Thrippleton MJ,Makin SD,et al.Cerebral blood flow in small vessel disease:A systematic review and meta-analysis[J].Journal of Cerebral Blood Flow and Metabolism,2016,36(10):1653-1667.
[5] Sam K,Crawley AP,Poublanc J,et al.Vascular dysfunction in leukoaraiosis[J].American Journal of Neuroradiology,2016,37(12):2258-2264.
[6] Maniega SM,Chappell FM,Hernandez MCV,et al.Integrity of normal-appearing white matter:Influence of age,visible lesion burden and hypertension in patients with small-vessel disease[J].Journal of Cerebral Blood Flow and Metabolism,2017,37(2):644-656.
[7] Farrall AJ,Wardlaw JM.Blood-brain barrier:Ageing and microvascular disease-systematic review and meta-analysis[J].Neurobiology of Aging,2009,30(3):337-352.
[8] Auriel E,Bornstein NM,Berenyi E,et al.Clinical,radiological and pathological correlates of leukoaraiosis[J].Acta Neurologica Scandinavica,2011,123(1):41-47.
[9] Zupan M,Sabovic M,Zaletel M,et al.The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis:A case control pilot study[J].Bmc Neurology,2015,15:158.
[10] Fernandez-Cadenas I,Mendioroz M,Domingues-Montanari S,et al.Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients[J].European Journal of Neurology,2011,18(6):826-835.
[11] Debette S,Schilling S,Duperron MG,et al.Clinical significance of magnetic resonance imaging markers of vascular brain injury:A systematic review and meta-analysis[J].JAMA Neurology,2019,76(1):81-94.
[12] Kuller LH,Longstreth WT,Arnold AM,et al.White matter hyperintensity on cranial magnetic resonance imaging:A predictor of stroke[J].Stroke,2004,35(8):1821-1825.
[13] Kumral E,Gulluoglu H,Alakbarova N,et al.Association of leukoaraiosis with stroke recurrence within 5 years after initial stroke[J].Journal of Stroke & Cerebrovascular Diseases,2015,24(3):573-582.
[14] Nagy M,Azeem MU,Soliman Y,et al.Pre-existing white matter hyperintensity lesion burden and diagnostic certainty of transient ischemic attack[J].Journal of Stroke & Cerebrovascular Diseases,2019,28(4):944-953.
[15] Park JH,Heo SH,Lee MH,et al.White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease[J].European Journal of Neurology,2019,26(6):911-918.
[16] Helenius J,Goddeau RP,Moonis M,et al.Impact of leukoaraiosis burden on hemispheric lateralization of the national institutes of health stroke scale deficit in acute ischemic stroke [J].Stroke,2016,47(1):24-30.
[17] Lou M,Al-Hazzani A,Goddeau RP,et al.Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage[J].Stroke,2010,41(1):34-40.
[18] Neumann-Haefelin T,Hoelig S,Berkefeld J,et al.Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke[J].Stroke,2006,37(10):2463-2466.
[19] Mi T,Zhao E,Zheng XY,et al.Leukoaraiosis with mild cognitive impairment[J].Neurological Research,2015,37(5):410-414.
[20] Smith EE,O'donnell M,Dagenais G,et al.Early cerebral small vessel disease and brainvolume,cognition,and gait[J].Annals of Neurology,2015,77(2):251-261.
[21] Zupan M.Pathogenesis of Leukoaraiosis:A review[M].Rijeka:Intech Europe,2016:155-173.
[22] 王 丰,李 莎,胡赛琴,等.基于弥散张量成像主观认知下降患者脑效应机制研究进展[J].陕西医学杂志,2022,51(1):117-120.
[23] Qian JF,Zhang Z,Qian F,et al.Relationship between depression after ischemic stroke and leukoaraiosis[J].Chinese Journal of Neuromedicine,2013,12(10):1043-1049.
[24] Liu X,Yu E,Wu W.Relationship between leukoaraiosis and depression in the elders[J].Chinese General Practice,2011,14(7):2264-2266.
[25] Grool AM,Geerlings MI,Sigurdsson S,et al.Structural MRI correlates of apathy symptoms in older persons without dementia AGES-reykjavik study[J].Neurology,2014,82(18):1628-1635.
[26] Bijanki KR,Stillman AN,Arndt S,et al.White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis[J].International Journal of Geriatric Psychiatry,2013,28(10):1069-1076.
[27] 闫红静,习旭涛,朱 琰,等.脑白质疏松症与前庭功能受损的相关性研究[J].陕西医学杂志,2017,46(10):1366-1368.
[28] 丁辉燕.复方苁蓉益智胶囊联合奥拉西坦治疗脑白质疏松认知障碍疗效观察[J].陕西中医,2017,38(8):991-992.
相似文献/References:
[1]苏建淳,张国义,卢秋霞,等.miR-124在鼻咽癌组织中的表达及其与预后关系研究*[J].陕西医学杂志,2020,49(2):144.
SU Jianchun,ZHANG Guoyi,LU Qiuxia,et al.Expression of miR-124 in nasopharyngeal carcinoma and its relationship with prognosis[J].,2020,49(6):144.
[2]弥婉军,王晓娟.胰高血糖素样肽-1蛋白对帕金森病氧化应激损伤的保护作用及机制研究[J].陕西医学杂志,2021,50(4):395.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.003]
MI Wanjun,WANG Xiaojuan.Protective effect and mechanism of GLP-1 protein on oxidative stress injury in Parkinson's disease[J].,2021,50(6):395.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.003]
[3]贾 涛,王晓忠,冯前翰.呲美莫司乳膏联合醋酸曲安奈德软膏治疗口腔扁平苔藓疗效及机制研究[J].陕西医学杂志,2021,50(11):1427.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.026]
[4]崔 凯,白峻峰,公孙鑫,等.Wiskott-Aldrich综合征蛋白家族成员3对非小细胞肺癌侵袭转移的影响及机制研究[J].陕西医学杂志,2021,50(12):1505.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.009]
CUI Kai,BAI Junfeng,GONGSUN Xin,et al.Effect and mechanism of WASF3-AS1 on invasion and metastasis of non-small cell lung cancer[J].,2021,50(6):1505.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.009]
[5]张新强,冯会成.振动刺激促进前交叉韧带重建后本体感觉恢复机制研究进展[J].陕西医学杂志,2022,51(1):125.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.031]
ZHANG Xinqiang,FENG Huicheng.Mechanism progress of vibration stimulation promoting proprioception recovery after anterior cruciate ligament reconstruction[J].,2022,51(6):125.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.031]
[6]袁 瑾,赵 灿,张渭涛.依普利酮通过靶向微小RNA-192和微小RNA-29a/b/c减轻糖尿病肾病模型大鼠肾损伤机制研究[J].陕西医学杂志,2022,51(3):293.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.007]
YUAN Jin,ZHAO Can,ZHANG Weitao.Mechanism of eplerenone alleviating renal injury in diabetic nephropathy rat model by targeting miR-192 and miR-29a/b/c[J].,2022,51(6):293.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.007]
[7]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(6):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[8]呼肖娜,李卫红.依那西普对银屑病大鼠模型固有淋巴细胞亚群分型的影响[J].陕西医学杂志,2022,51(8):921.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.004]
HU Xiaona,LI Weihong.Effect of etanercept on typing of innate lymphocyte subsets in a rat model of psoriasis[J].,2022,51(6):921.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.004]
[9]李 鹏,李晓博,王林钦.神经干细胞促进大鼠局部神经元降钙素基因相关肽生成及脊柱骨折愈合机制研究[J].陕西医学杂志,2022,51(9):1066.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.005]
LI Peng,LI Xiaobo,WANG Linqin.Mechanism of neural stem cell promoting calcitonin gene-related peptide production in local neurons and spinal fracture healing in rats[J].,2022,51(6):1066.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.005]
[10]聂清华,李 飞.右美托咪定对异氟烷麻醉引起的老年小鼠认知功能障碍保护作用及机制研究[J].陕西医学杂志,2023,52(1):18.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.004]
NIE Qinghua,LI Fei.Protective effect and mechanism of dexmedetomidine on isoflurane anesthesia-induced cognitive impairment in old mice[J].,2023,52(6):18.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.004]